Form 4: CEO Fumihide Esaka Executes Stock Options and Sale
Statement of Changes in Beneficial Ownership
Ambiq Micro CEO Fumihide Esaka exercised stock options and sold 60,000 shares of common stock.
Summary
- CEO Fumihide Esaka exercised options to acquire 120,000 shares of common stock across May 14 and May 15, 2026.
- The exercise prices for these options were $8.12 and $12.60 per share.
- Following the exercises, the CEO sold 60,000 shares at a weighted average price of $70.0187 per share.
- The CEO retains a beneficial ownership of 451,189 shares of common stock following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents routine executive equity management rather than a strategic shift or distress signal.
Positives
- The CEO maintains a significant equity stake of 451,189 shares in the company.
- The transaction reflects the exercise of long-term incentive options, indicating historical alignment with company growth.
Negatives
- The sale of 60,000 shares represents a liquidity event for the executive, reducing direct holdings by that amount.
Risks
- Future share price volatility could impact the value of remaining unexercised options and held equity.
Future Outlook
No specific forward-looking guidance provided in this regulatory filing.
Management Comments
- The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the range of $70.00 to $70.45 upon request.
Industry Context
StockSavvy.ai notes that executive stock sales are common occurrences for liquidity and tax planning purposes and do not necessarily reflect a change in the CEO's outlook on the company's long-term prospects.
Comparison to Industry Standards
- The exercise and sale pattern is consistent with standard executive compensation and equity management practices in the semiconductor industry.
Stakeholder Impact
- Shareholders should note the change in insider ownership, though the CEO remains heavily invested in the company's success.
Next Steps
- Continued monitoring of future Form 4 filings for further insider activity.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Earliest transaction date for option exercise and share sale. |
| 05/15/2026 | Additional option exercise transactions. |
| 05/18/2026 | Date of filing. |
Keywords
Ambiq Micro, AMBQ, Insider Trading, Form 4, Executive Compensation, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.